Business Description
A Plus Biotechnology Co Ltd
ISIN : TW0006918006
Description
A Plus Biotechnology Co Ltd provides orthopedic implants. It engages in the research and development of orthopedic medical products. Aplus locking plate systems feature superior anatomical bone curves and 5-axis CNC manufacturing technology.
Financial Strength
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 3.59 | |||||
| Equity-to-Asset | 0.73 | |||||
| Debt-to-Equity | 0.12 | |||||
| Debt-to-EBITDA | 1.03 | |||||
| Interest Coverage | 78.39 | |||||
| Piotroski F-Score | 8/9 | |||||
| Altman Z-Score | 7.66 | |||||
| Beneish M-Score | -3.28 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 8.2 | |||||
| 3-Year EBITDA Growth Rate | -1.8 | |||||
| 3-Year EPS without NRI Growth Rate | -0.2 | |||||
| 3-Year FCF Growth Rate | 9.8 | |||||
| 3-Year Book Growth Rate | 2.4 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 21.86 | |||||
| 9-Day RSI | 27.06 | |||||
| 14-Day RSI | 31.91 | |||||
| 6-1 Month Momentum % | 26.81 | |||||
| 12-1 Month Momentum % | 92.1 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 3.85 | |||||
| Quick Ratio | 2.61 | |||||
| Cash Ratio | 1.71 | |||||
| Days Inventory | 484.35 | |||||
| Days Sales Outstanding | 74.47 | |||||
| Days Payable | 55.44 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Dividend Yield % | 3.42 | |||||
| Dividend Payout Ratio | 0.37 | |||||
| Forward Dividend Yield % | 3.42 | |||||
| 5-Year Yield-on-Cost % | 3.42 | |||||
| 3-Year Average Share Buyback Ratio | -1.8 | |||||
| Shareholder Yield % | 4.56 |
Profitability Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 69.98 | |||||
| Operating Margin % | 26.86 | |||||
| Net Margin % | 7.9 | |||||
| FCF Margin % | 25.17 | |||||
| ROE % | 6.46 | |||||
| ROA % | 4.88 | |||||
| ROIC % | 21.21 | |||||
| ROC (Joel Greenblatt) % | 13.87 | |||||
| ROCE % | 7.79 | |||||
| Years of Profitability over Past 10-Year | 5 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 42.45 | |||||
| PE Ratio without NRI | 42.36 | |||||
| Price-to-Owner-Earnings | 286.02 | |||||
| PS Ratio | 3.38 | |||||
| PB Ratio | 2.78 | |||||
| Price-to-Tangible-Book | 2.95 | |||||
| Price-to-Free-Cash-Flow | 13.44 | |||||
| Price-to-Operating-Cash-Flow | 13.04 | |||||
| EV-to-EBIT | 28.77 | |||||
| EV-to-EBITDA | 21.37 | |||||
| EV-to-Revenue | 3.07 | |||||
| EV-to-FCF | 12.2 | |||||
| Price-to-Graham-Number | 2.36 | |||||
| Price-to-Net-Current-Asset-Value | 4.46 | |||||
| Price-to-Net-Cash | 38.74 | |||||
| Earnings Yield (Greenblatt) % | 3.48 | |||||
| FCF Yield % | 7.39 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
A Plus Biotechnology Co Ltd Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil NT$) | 713.741 | ||
| EPS (TTM) (NT$) | 1.88 | ||
| Beta | 0 | ||
| Volatility % | 46.88 | ||
| 14-Day RSI | 31.91 | ||
| 14-Day ATR (NT$) | 2.21886 | ||
| 20-Day SMA (NT$) | 86.295 | ||
| 12-1 Month Momentum % | 92.1 | ||
| 52-Week Range (NT$) | 43.85 - 96.9 | ||
| Shares Outstanding (Mil) | 30.47 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 8 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
A Plus Biotechnology Co Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
A Plus Biotechnology Co Ltd Stock Events
| Event | Date | Price(NT$) | ||
|---|---|---|---|---|
| No Event Data | ||||
A Plus Biotechnology Co Ltd Frequently Asked Questions
What is A Plus Biotechnology Co Ltd(ROCO:6918)'s stock price today?
The current price of ROCO:6918 is NT$79.80. The 52 week high of ROCO:6918 is NT$96.90 and 52 week low is NT$43.85.
When is next earnings date of A Plus Biotechnology Co Ltd(ROCO:6918)?
The next earnings date of A Plus Biotechnology Co Ltd(ROCO:6918) is .
Does A Plus Biotechnology Co Ltd(ROCO:6918) pay dividends? If so, how much?
The Dividend Yield %  of A Plus Biotechnology Co Ltd(ROCO:6918) is 3.42% (As of Today), Highest Dividend Payout Ratio of A Plus Biotechnology Co Ltd(ROCO:6918) was 0.68. The lowest was 0.37. And the median was 0.68. The  Forward Dividend Yield % of A Plus Biotechnology Co Ltd(ROCO:6918) is 3.42%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers